Header Logo

Connection

Fatima Laher to Alum Compounds

Back to Details
This is a "connection" page, showing publications Fatima Laher has written about Alum Compounds.
Fatima Laher
Connection Strength
0,235
Alum Compounds
  1. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial. PLoS Med. 2024 Mar; 21(3):e1004360.
    View in: PubMed
    Score: 0,235
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.